RUSSELL ANDERSON: Open Payments
NPI 1548407513 · TOOELE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 18 payments from 10 companies in 2025. Trend: 2023 $347 · 2024 $472 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Novo Nordisk Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $40 |
| Indivior Inc. | 2 | $40 |
| Medtronic, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, Cologuard Collection Kit, SUBLOCADE, INCEPTIV, Ozempic, OTEZLA, MOUNJARO.
Industry payments across UT — which companies pay providers there.
